Oyo PHC has engaged VIYA Health in strategic discussions aimed at expanding access to DMPA SC, a World Health Organization-pre-qualified family planning solution, according to a BusinessDay Nigeria report published on 25 August 2026.
VIYA Health is the exclusive distributor in Nigeria of the DMPA SC product manufactured by Incepta Pharmaceuticals. The available report identifies broader access as the focus of the engagement, but does not specify the areas or facilities that could be covered by any proposed expansion.
The discussions bring together an Oyo health-sector body and the product’s exclusive Nigerian distributor. That connection is relevant to potential availability because VIYA Health manages the product’s distribution in the country, while the engagement is centred on access in Oyo.
It is not yet known whether the discussions produced a formal agreement or operational plan. No information was supplied on projected volumes, funding, pricing, participating health facilities, implementation dates or the number of people who might be reached.
Further details would be needed to establish how the proposed expansion would work and when it might begin. For now, the confirmed development is that Oyo PHC and VIYA Health have opened strategic discussions around widening access to the WHO-pre-qualified family planning solution.